FDA Inspection 1191165 — AbbVie Inc.
The FDA completed an inspection of AbbVie Inc. on Oct 6, 2022 in North Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 6, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Chicago, IL (United States)
Additional Details
Sponsor, Contract Research Organization